Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 116.6 to 96.3.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2026
Arysta LifeScience Ougrée Production from Seraing, company number BE0403054004, closed financial year 2026 with a result of € 1.7 million after tax. For that financial year Arysta LifeScience Ougrée Production recorded revenue of € 27.7 million and equity of € 22.8 million. Compared with financial year 2025, the result moved from € 1.8 million to € 1.7 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 28, 2026.
€ 22.8 million
▲ 8% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.7 million
▼ 4% vs 2025
Profit after tax over the fiscal year.
€ 17,520
▼ 46% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 19.8 million.
People and assets in 2026
96.3
▼ 5.7 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 9.5 million
▼ 4% vs 2025
€ 98,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 227,551
▼ 32% vs 2025
Of which on lease € 214,356.
Debts at end 2026
€ 304,228
▼ 31% vs 2025
€ 94,171 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 3.9 million
▲ 3% vs 2025
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 96 days on average.
€ 2.6 million
▼ 9% vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 30,375,814 | € 23,946,877 | € 24,813,111 | € 27,678,890 | ▲ 12% |
| Profit after taxes | € 3,883,796 | € 1,725,599 | € 1,804,639 | € 1,729,655 | ▼ 4% |
| Equity | € 17,585,245 | € 19,310,844 | € 21,115,483 | € 22,845,138 | ▲ 8% |
| Total debts | € 8,970,851 | € 6,714,901 | € 7,134,654 | € 6,841,732 | ▼ 4% |
| Cash | € 138,709 | € 29,868 | € 32,472 | € 17,520 | ▼ 46% |
| Land & buildings | € 1,704,063 | € 1,752,517 | € 1,516,294 | € 1,311,945 | ▼ 13% |
| Retained profit | € 14,521,337 | € 16,246,936 | € 18,051,575 | € 19,781,230 | ▲ 10% |
| Bank debt | € 612,976 | € 529,179 | € 443,234 | € 304,228 | ▼ 31% |
| Balance sheet total | € 26,556,096 | € 26,025,745 | € 28,250,137 | € 29,686,870 | ▲ 5% |
| Employees (FTE) | 123.5 | 116.6 | 102 | 96.3 | ▼ 5.7 |
Key figures of Arysta LifeScience Ougrée Production, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to Arysta LifeScience Ougrée Production?
What happened at Arysta LifeScience Ougrée Production in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 1.7 million (▼ 4% vs 2025). Source: NBB ↗
- Mandar Jayant KADAM became a director. NBB
- Guilhem LAFAIGE DE GAILLARD became a director. NBB
- New establishment in Seraing. KBO
- Start of the company according to the CBE. KBO
In short
From € 3.9 million profit in 2023 to € 1.7 million profit in 2026.
Paid € 3.7 million in corporate taxes since 2023.
Best year ever: 2023, with € 3.9 million profit.
Pays suppliers within 96 days on average.
Management
Behind Arysta LifeScience Ougrée Production are Mandar Jayant KADAM and Guilhem LAFAIGE DE GAILLARD. Mandar Jayant KADAM is also behind ARYSTA LIFESCIENCE BENELUX.
Directors
According to the 2026 annual accounts
since 2019
Guilhem LAFAIGE DE GAILLARD
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Rue de Renory 26 box 1
4102 Seraing
Rue de Renory 26 box 2
4102 Seraing
Active since 1 January 1982
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0403.054.004
- VAT number
- BE 0403.054.004
- Registered office
- Rue de Renory 26 bus 1, 4102 Seraing
- Names & denominations
- Arysta LifeScience Ougrée Production
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 August 1945
- Peppol
- Active · Active since 4 Jun 2026
- Activities · NACE
Vervaardiging van verdelgingsmiddelen en van andere chemische producten voor de landbouw
Vervaardiging van verdelgingsmiddelen, ontsmettingsmiddelen en andere chemische producten voor de landbouw
Vervaardiging van kunstmeststoffen en stikstofverbindingen
Vervaardiging van kunstmeststoffen
Vervaardiging van parfums en toiletartikelen
Vervaardiging van parfums en cosmetische artikelen